Upregulation of miR-101 during Influenza A Virus Infection Abrogates Viral Life Cycle by Targeting mTOR Pathway.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 10 02 2020
revised: 22 03 2020
accepted: 29 03 2020
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 16 2 2021
Statut: epublish

Résumé

Micro RNAs (miRNAs) are a class of small non-coding single-stranded RNA, which play an important role in modulating host-Influenza A virus (IAV) crosstalk. The interplay between influenza and miRNA interaction is defined by a plethora of complex mechanisms, which are not fully understood yet. Here, we demonstrate that in IAV infected A549 cells, a synchronous increase was observed in the expression of mTOR up to 24 hpi and significant downregulation at 48 hpi. Additionally, NP of IAV interacts with mTOR and modulates the levels of mTOR mRNA and protein, thus regulating the translation of host cell. RNA sequencing and qPCR analysis of IAV-infected A549 cells and NP transfected cells revealed that miR-101 downregulates mTOR transcripts at later stages of infection. Ectopic expression of miR-101 mimic led to a decrease in expression of NP, a reduction in IAV titer and replication. Moreover, treatment of the cells with Everolimus, a potent inhibitor of mTOR, resulted in an increase of miR-101 transcript levels, which further suppressed the viral protein synthesis. Collectively, the data suggest a novel mechanism that IAV stimulates mTOR pathway at early stages of infection; however, at a later time-point, positive regulation of miR-101 restrains the mTOR expression, and hence, the viral propagation.

Identifiants

pubmed: 32326380
pii: v12040444
doi: 10.3390/v12040444
pmc: PMC7232138
pii:
doi:

Substances chimiques

MIRN101 microRNA, human 0
Membrane Proteins 0
MicroRNAs 0
Oncogene Protein v-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
GTP Phosphohydrolases EC 3.6.1.-
NRAS protein, human EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Biomed Res Int. 2017;2017:7082696
pubmed: 29259984
Mol Genet Genomics. 2015 Oct;290(5):1885-97
pubmed: 25893419
PLoS One. 2011;6(6):e20215
pubmed: 21698289
Virology. 2014 Nov;468-470:256-264
pubmed: 25203353
Viruses. 2017 Apr 27;9(5):
pubmed: 28448456
Mol Ther Nucleic Acids. 2018 Mar 2;10:361-375
pubmed: 29499948
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
J Cell Sci. 2015 Apr 15;128(8):1607-16
pubmed: 25717002
Genome Biol. 2010;11(10):R106
pubmed: 20979621
FEBS J. 2014 Jul;281(13):2899-914
pubmed: 24802111
Cancer Res. 2010 Jun 15;70(12):5184-93
pubmed: 20501828
Med Sci Monit. 2011 Jun;17(6):RA148-54
pubmed: 21629204
Mol Cell Biol. 2018 May 29;38(12):
pubmed: 29610153
N Engl J Med. 2013 May 2;368(18):1685-94
pubmed: 23534542
Front Immunol. 2018 Jul 04;9:1541
pubmed: 30022983
J Virol. 2019 Feb 5;93(4):
pubmed: 30541828
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
Sci Signal. 2015 Dec 08;8(406):ra126
pubmed: 26645583
J Biol Chem. 2017 Dec 29;292(52):21291-21303
pubmed: 29046356
Bioinformatics. 2012 Aug 1;28(15):2059-61
pubmed: 22628521
J Biol Chem. 2012 Sep 7;287(37):31027-40
pubmed: 22822053
Plant Methods. 2007 Oct 12;3:12
pubmed: 17931426
Mol Endocrinol. 2010 Feb;24(2):447-63
pubmed: 20081105
Essays Biochem. 2017 Dec 12;61(6):565-584
pubmed: 29233869
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
pubmed: 24275495
Genome Biol. 2009;10(3):R25
pubmed: 19261174
PLoS Pathog. 2017 Sep 27;13(9):e1006635
pubmed: 28953980
J Exp Med. 2014 Oct 20;211(11):2281-95
pubmed: 25311506
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
pubmed: 14973191
J Biol Chem. 2012 Jun 8;287(24):20545-54
pubmed: 22523071
Nat Cell Biol. 2001 Mar;3(3):301-5
pubmed: 11231581
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
Nucleic Acids Res. 2009 Mar;37(4):1035-48
pubmed: 19095692
PLoS One. 2013 Oct 07;8(10):e76811
pubmed: 24116168
J Virol. 2008 Sep;82(18):9065-74
pubmed: 18596100
Cell Death Dis. 2015 Dec 17;6:e2018
pubmed: 26673663
J Cell Biol. 2013 Nov 25;203(4):563-74
pubmed: 24385483
Med Oncol. 2010 Jun;27(2):255-61
pubmed: 19301157
Nat Rev Microbiol. 2011 Jul 11;9(8):590-603
pubmed: 21747392
Exp Biol Med (Maywood). 2016 Feb;241(4):409-20
pubmed: 26518627
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Gynecol Oncol. 2011 Apr;121(1):8-12
pubmed: 21276607
Pigment Cell Melanoma Res. 2011 Feb;24(1):254-7
pubmed: 21029395
Virology. 2013 Dec;447(1-2):84-94
pubmed: 24210102
J Virol Methods. 2003 Jun 9;110(1):67-71
pubmed: 12757922
Indian J Microbiol. 2009 Dec;49(4):332-8
pubmed: 23100794
PLoS One. 2018 Apr 20;13(4):e0194765
pubmed: 29677213
J Gen Virol. 2007 Mar;88(Pt 3):942-50
pubmed: 17325368
PLoS One. 2011 Jan 20;6(1):e16324
pubmed: 21283725
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Shipra Sharma (S)

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.

Anirvan Chatterjee (A)

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.

Purnima Kumar (P)

Virology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi 110067, India.

Sunil Lal (S)

School of Science, Monash University, Bandar Sunway 47500, Malaysia.

Kiran Kondabagil (K)

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH